Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Dr. med. Frederik Krefting

Funktionen

  • Assistenzarzt/-ärztin, Klinik für Dermatologie

Aktuelle Veranstaltungen

Keine aktuellen Veranstaltungen.

Vergangene Veranstaltungen (max. 10)

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Krefting, Frederik; Hölsken, S.; Sondermann, Wiebke; Schedlowski, Manfred
    Hypothalamic pituitary adrenal axis hormone changes during IL-17A inhibition with secukinumab in patients with psoriasis
    In: Clinical Immunology, Jg. 282, 2026, 110611
    DOI (Open Access)
  • Thielmann, Carl Maximilian; Krefting, Frederik; Sondermann, Wiebke
    BASCULE-Syndrom bei einer 12-jährigen Patientin : Dermatologischer Schnappschuss
    In: Die Dermatologie, Jg. 76, 2025, Nr. 6, S. 371
    DOI
  • Krefting, Frederik; Scheib, Cosima; Benson, Sven; Hölsken, Stefanie; Placke, Jan-Malte; Wedemeyer, Heiner; Sondermann, Wiebke
    Baseline Pathological Liver Function Tests in Patients with Psoriasis Support the Indication for Systemic Therapy Rather than Being a Reason against it : A Real-World Analysis
    In: Psoriasis: Targets and Therapy, Jg. 15, 2025, S. 29 – 44
    DOI (Open Access)
  • Sondermann, Wiebke; Krefting, Frederik
    Hautreaktionen unter Biologikatherapie
    In: Zeitschrift für Rheumatologie, 2025, in press
    DOI
  • Placke, Jan-Malte; Rajcsanyi, Luisa Sophie; Herbst, Rudolf; Terheyden, Patrick; Utikal, Jochen; Pföhler, Claudia; Kreuter, Alexander; Mohr, Peter; Gutzmer, Ralf; Weichenthal, Michael; Meier, Friedegund; Berking, Carola; Leiter, Ulrike; Seier, Johanna; Krefting, Frederik; Tasdogan, Alpaslan; Lodde, Georg; Livingstone, Elisabeth; Zimmer, Lisa; Rösch, Alexander; Griewank, Klaus; Schadendorf, Dirk; Ugurel, Selma
    Presence of brain metastasis differentially impacts long-term survival after first-line therapy in melanoma depending on BRAF mutation status
    In: Frontiers in Immunology, Jg. 16, 2025, 1536642
    DOI, Online Volltext (Open Access)
  • Hölsken, Stefanie; Krefting, Frederik; Mühlhaus, Senta; Bese, Daniela; Schedlowski, Manfred; Sondermann, Wiebke
    Shaping Treatment Expectation to Optimize Efficacy of Interleukin 17A Antagonist Secukinumab in Psoriasis Patients
    In: Psoriasis: Targets and Therapy, Jg. 15, 2025, S. 9 – 22
    DOI (Open Access)
  • Moelleken, Maurice; Krimphove, Sebastian Heinrich; Krefting, Frederik; Rammos, Christos; Cyrek, Anna Ewa; Benson, Sven; Dissemond, Joachim
    Wound dressings protect against bacterial environment : results of a prospective clinical study
    In: Journal of Wound Care, Jg. 34, 2025, Nr. 8, S. 564 – 570
    DOI
  • Krefting, Frederik; Welzel, Julia; Thamm, Janis; Thölken, Karisa; Wohlrab, Johannes; Müller, Valentina Laura; Kreuter, Alexander; Rueff, Franziska; Sticherling, Michael; Hölsken, Stefanie; Placke, Jan-Malte; Sondermann, Wiebke
    Analysis of the German Compassionate Use Program on spesolimab in patients with generalized pustular psoriasis : Evidence outside of clinical trials
    In: European Journal of Dermatology (EJD), Jg. 34, 2024, Nr. 6, S. 643 – 650
    DOI
  • Albrecht, Jessica Lea; Dimitriou, Florentia; Grover, Piyush; Hassel, Jessica C.; Erdmann, Michael; Forschner, Andrea; Johnson, Douglas B.; Váraljai, Renáta; Lodde, Georg; Placke, Jan-Malte; Krefting, Frederik; Zaremba, Anne; Ugurel, Selma; Rösch, Alexander; Schulz, Carsten; Berking, Carola; Pöttgen, Christoph; Menzies, Alexander M.; Long, Georgina V.; Dummer, Reinhard; Livingstone, Elisabeth; Schadendorf, Dirk; Zimmer, Lisa
    Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanoma
    In: European Journal of Cancer (EJC), Jg. 202, 2024, 113976
    DOI (Open Access)
  • Krefting, Frederik; Moelleken, Maurice; Hölsken, Stefanie; Placke, Jan-Malte; Eisenburger, Robin Tamara; Albrecht, Jessica Lea; Tasdogan, Alpaslan; Schadendorf, Dirk; Ugurel, Selma; Dissemond, Joachim; Sondermann, Wiebke
    Comparison of visual diagnostic accuracy of dermatologists practicing in Germany in patients with light skin and skin of color
    In: Scientific Reports, Jg. 14, 2024, Nr. 1, 8740
    DOI, Online Volltext (Open Access)
  • Moelleken, Maurice; Krimphove, Sebastian Heinrich; Krefting, Frederik; Benson, Sven; Rammos, Christos; Cyrek, Anna Ewa; Dissemond, Joachim
    How effective is simple mechanical wound debridement in reducing bacterial colonisation? : Results of a prospective clinical study
    In: International Wound Journal (IWJ), Jg. 21, 2024, Nr. 4, e14824
    DOI, Online Volltext (Open Access)
  • Hölsken, Stefanie; Benthin, Carina; Krefting, Frederik; Mühlhaus, Senta; Nestoriuc, Yvonne; Schedlowski, Manfred; Sondermann, Wiebke
    “I Was Almost in Disbelief” : Qualitative Analysis of Experiences and Expectations Among Psoriasis Patients Undergoing Biologic Treatment with Secukinumab
    In: Patient Preference and Adherence, Jg. 18, 2024, S. 1299 – 1310
    DOI (Open Access)
  • Krefting, Frederik; Hölsken, Stephanie; Schedlowski, Manfred; Sondermann, Wiebke
    Einfluss der Behandlungserwartung auf Pruritus und Hautschmerzen
    In: Der Schmerz, Jg. 36, 2022, Nr. 3, S. 189 – 195
    DOI (Open Access)

    • Abstracts

  • Hölsken, Stefanie; Holubek, Eva; Krefting, Frederik; Mühlhaus, Senta; Schedlowski, Manfred; Sondermann, Wiebke
    Alleviating allergic skin responses : Preliminary data of a conditioning and open label placebo paradigm
    28th Annual Meeting of the PsychoNeuroImmunology-Research-Society; JUN 15-18, 2022; Zurich, Switzerland,
    In: Brain, Behavior and Immunity. Amsterdam: Elsevier, Jg. 106, 2022, Nr. Supplement, S. 6
    DOI
  • Ferdinandus, Justin; Barbato, Francesco; Chodyla, Michal; Fendler, Wolfgang P.; Kessler, Lukas; Metzenmacher, Martin; Krefting, Frederik; Hager, Thomas; Herrmann, Ken; Christoph, Daniel
    PERCIST-derived metabolic volume response predicts overall and progression-free survival in patients with malignant pleural mesothelioma treated with Pembrolizumab
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S353
    DOI (Open Access)
  • Ferdinandus, Justin; Barbato, Francesco; Chodyla, Michal; Fendler, Wolfgang; Kessler, Lukas; Metzenmacher, Martin; Krefting, Frederik; Hager, Thomas; Herrmann, Ken; Christoph, Daniel
    PERCIST-derived metabolic volume response predicts overall and progression-free survival in patients with malignant pleural mesothelioma treated with Pembrolizumab
    Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, July 11-14, 2020, Virtual,
    In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. Suppl. 1, 243
    Online Volltext (Open Access)
  • Christoph, Daniel; Barbato, Francesco; Chodyla, Michal; Fendler, Wolfgang P.; Kessler, Lukas; Pomykala, Kelsey L.; Metzenmacher, Martin; Krefting, Frederik; Hager, Thomas; Herrmann, Ken; Ferdinandus, Justin
    Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma
    ESMO Virtual Congress 2020, 19.-21.09- und 16.-18.10.2020,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 31, 2020, Nr. Suppl. 4, S. S1076 – S1077
    DOI (Open Access)